Multidimensional Efficacy between Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: A 12-Week Randomized Controlled Trial
International Journal of Psychiatry and Neurology · 2026 · 15 (04) · 135-154
DOI: 10.12677/ijpn.2026.154016 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Psychiatry and Neurology, 2026. Verfasst von 雪竹 黄. Die Arbeit nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
黄, 雪. (2026). Multidimensional Efficacy between Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: A 12-Week Randomized Controlled Trial. International Journal of Psychiatry and Neurology, 15(04), 135-154. https://doi.org/10.12677/ijpn.2026.154016
Vancouver
黄 雪. Multidimensional Efficacy between Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: A 12-Week Randomized Controlled Trial. International Journal of Psychiatry and Neurology. 2026;15(04):135-154. doi:10.12677/ijpn.2026.154016
BibTeX
@article{2026,
author = {黄, 雪竹},
title = {Multidimensional Efficacy between Methylphenidate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: A 12-Week Randomized Controlled Trial},
journal = {International Journal of Psychiatry and Neurology},
year = {2026},
volume = {15},
number = {04},
pages = {135--154},
doi = {10.12677/ijpn.2026.154016}
}
EUVIMED